VIVEVE MEDICAL, INC. 4 SEC Filings

Filed On	Filing
05 Jan 2023	Form 4: Basta Steven L, Director Granted 72,000 Restricted Stock Unit
05 Jan 2023	Form 4: Durbin Scott, Director Granted 360,000 Restricted Stock Unit
05 Jan 2023	Form 4: Jorn Debora, Director Granted 36,000 Restricted Stock Unit
05 Jan 2023	Form 4: Morris Arlene, Director Granted 36,000 Restricted Stock Unit
05 Jan 2023	Form 4: Presnell Sharon Collins, Director Granted 36,000 Restricted Stock Unit
05 Jan 2023	Form 4: Robbins Jim B, SVP, Finance & Administration Granted 57,000 Restricted Stock Unit
06 Jan 2022	Form 4: Jorn Debora, Director Granted 22,000 Non-Qualified Stock Option (Right to Purchase)
06 Jan 2022	Form 4: Morris Arlene, Director Granted 22,000 Non-Qualified Stock Option (Right to Purchase)
06 Jan 2022	Form 4: Presnell Sharon Collins, Director Granted 18,000 Non-Qualified Stock Option (Right to Purchase)
06 Jan 2022	Form 4: Robbins Jim B, SVP, Finance & Administration Granted 42,000 Incentive Stock Option (Right to Purchase)
06 Jan 2022	Form 4: Basta Steven L, Director Granted 48,000 Non-Qualified Stock Option (Right to Purchase)
06 Jan 2022	Form 4: Durbin Scott, Chief Executive Officer Granted 258,000 Incentive Stock Option (Right to Purchase)
17 Dec 2021	Form 4: Basta Steven L, Director Returned 28 shares to the issuer ($39.5)
17 Dec 2021	Form 4: Durbin Scott, Chief Executive Officer Returned 2 shares to the issuer ($2.8)
17 Dec 2021	Form 4: Robbins Jim B, SVP, Finance & Administration Returned 36 shares to the issuer ($51.5)
25 Jun 2021	Form 4: Basta Steven L, Director Granted 116,200 Non-Qualified Stock Option (Right to Purchase)
25 Jun 2021	Form 4: Durbin Scott, Director Granted 655,300 Incentive Stock Option (Right to Purchase)
25 Jun 2021	Form 4: Morris Arlene, Director Granted 51,700 Non-Qualified Stock Option (Right to Purchase)
25 Jun 2021	Form 4: Jorn Debora, Director Granted 51,700 Non-Qualified Stock Option (Right to Purchase)
25 Jun 2021	Form 4: Presnell Sharon Collins, Director Granted 39,000 Non-Qualified Stock Option (Right to Purchase)

Comments